Hospital.Help

Silver Spring/Maryland – A controversial new treatment for post-traumatic stress disorder using the chemical compound MDMA, also known as ecstasy, has suffered a double setback in the USA. First, the manufacturer announced that the… [weiter lesen]

#PTSD #FDA #rejects #MDMAbased #drug #Journal #withdraws #studies